Related Topics News -

     
 Title only   |   Print    Next page > 
     
派格生物醫藥與SN BIOSCIENCE開展聯合研發合作

2026-09-02T  
《業績》派格生物醫藥中期虧損擴大至2.16億人幣

2026-08-25T  
派格生物醫藥飆逾四成 與美國醫藥公司Rani簽合作備忘

2026-07-10T  
派格生物收到騰瑞製藥維培那肽商業化合作首筆權益金6,100萬元

2026-06-08T  
派格生物醫藥基石投資者禁售期延至下月20日

2026-04-28T  
派格生物醫藥創新候選產品CR059入選ADA最新突破性摘要

2026-04-07T  
《業績》派格生物醫藥全年虧損收窄至2.08億人民幣

2026-03-23T  
派格生物與騰瑞製藥達成商業化合作 目標規模逾百億人民幣

2026-03-16T  
派格生物醫藥每手改50股買賣 本月31日生效

2026-03-10T  
派格生物醫藥:新一代GLP-1首次人體試驗取得一個月臨床觀察結果

2026-03-06T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.